Oral strategies to target proprotein convertase subtilisin/kexin type 9 and lipoprotein(a): the new frontier of lipid lowering

Araştırma sonucu: Dergiye katkı › Makale › bilirkişi

1 Alıntı (Scopus)

Belgeye Erişim

@article{a69e0ae6f81f47158bd599252e06375f,

title = "Oral strategies to target proprotein convertase subtilisin/kexin type 9 and lipoprotein(a): the new frontier of lipid lowering",

author = "Norata, \{Giuseppe Danilo\} and Lale Tokg{\"o}zoğlu",

year = "2023",

month = dec,

day = "21",

doi = "10.1093/eurheartj/ehad682",

language = "English",

volume = "44",

pages = "5018--5020",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "48",

}

TY - JOUR

T1 - Oral strategies to target proprotein convertase subtilisin/kexin type 9 and lipoprotein(a)

T2 - the new frontier of lipid lowering

AU - Norata, Giuseppe Danilo

AU - Tokgözoğlu, Lale

PY - 2023/12/21

Y1 - 2023/12/21

UR - https://www.scopus.com/pages/publications/85181262504

U2 - 10.1093/eurheartj/ehad682

DO - 10.1093/eurheartj/ehad682

M3 - Article

C2 - 37947270

AN - SCOPUS:85181262504

SN - 0195-668X

VL - 44

SP - 5018

EP - 5020

JO - European Heart Journal

JF - European Heart Journal

IS - 48

ER -